Researchers at Queen Mary, University of London, studied equivalent cells taken from mouse brains. Principal investigator Silvia Marino, Professor of Neuropathology at Queen Mary, University of London, and her team showed that medulloblastomas can grow from a type of brain stem cell and that these cancers are a distinct form of the disease which may require a completely different approach to treatment.
Like a Hole in the Head: Living with a Brain Tumour
Dr Foteini Hassiotou has discovered stem cells can be obtained from breast milk
Serious and fatal diseases such as pancreatic cancer, Parkinson‘s disease and diabetes may eventually be treated using stem cells from breast milk following a remarkable discovery at the University of Western Australia.
UWA PhD student Foteini Hassiotou has potentially broken through the greatest hurdle in stem cell research – the ability to ethically obtain stem cells in a non-invasive manner.
Her finding that stem cells from breast milk can be directed to become other body cell types such as bone, fat, liver and brain cells, could reduce the
Everyday new avenues are being explored to find novel therapies for hard to treat diseases. One exciting new approach is the use of autologous Adult Stem Cells. Multiple Sclerosis (MS) is one of the many notable diseases adult stem cell therapy could potentially impact. Multiple Sclerosis (MS) is a disorder in which an individual’s own immune system attacks the ‘myelin sheath’. The myelin sheath serves to protect the nerve cells within the body’s central nervous system (CNS). In addition to fatigue and depression, the damage caused by MS may result in many types of mild and severe
A revolutionary stem cell procedure may be able to stop ALS, or Lou Gehrig‘s disease, in its tracks.
HealthFirst reporter Leslie Toldo shares the story of one of the few people who have had it done.
ALS is a deadly disease, with a quick and devastating decline. This could be the hope thousands of people have been waiting for.
Fifty-five-year-old Tom Elliott is not a quitter. He has ALS and fights to keep up with the daily routines of his life, even as the disease makes everything harder. “Brushing the teeth has become a real chore. Turning and rolling in bed to
Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in stem cells (…)
The relatively small payment reflects that “it’s really early for cell therapy and there’s more research to be done,” said Ruth McKernan, chief scientific officer of Pfizer Regenerative Medicine, a unit created by the company about 18 months ago to develop treatments based on stem cells (…)